Table 1 Clinical characteristics of patients in the bleeding and non-rebleeding groups
Variables | No-rebleeding n = 1035 (88.5%) | Rebleeding n = 135 (11.5%) | P-value |
|---|---|---|---|
Gender (male) | 767 (74.1%) | 104 (77%) | 0.463 |
Age | 56 (42, 67) | 62 (53, 68) | 0.004 |
Hematemesis | 536 (51.8%) | 87 (64.4%) | 0.006 |
Melena | 858 (82.9%) | 107 (79.3%) | 0.295 |
Medication history | |||
NSAIDs | 115 (11.1%) | 15 (11.1%) | 1 |
Antiplatelet | 45 (4.3%) | 3 (2.2%) | 0.242 |
Anticoagulants | 19 (1.8%) | 2 (1.4%) | 0.771 |
Diabetes | 132 (12.8%) | 24 (17.8%) | 0.106 |
Hypertension | 276 (26.7%) | 32 (23.7%) | 0.462 |
Coronary heart disease | 102 (9.9%) | 12 (8.9%) | 0.722 |
Clinical data | |||
Systolic blood pressure (mmHg) | 115 (103, 128) | 115 (103, 134) | 0.924 |
Diastolic blood pressure (mmHg) | 67 (60, 76) | 66 (55, 80) | 0.130 |
Heart rate (beats/min) | 90 (78, 105) | 92 (79, 105) | 0.445 |
Mean arterial pressure(mmHg) | 84 (75, 93) | 81 (71, 99) | 0.288 |
Shock index | 0.78 (0.66, 0.93) | 0.82 (0.64, 0.96) | 0.398 |
Lab results | |||
LAC (mmol/L) | 1.5 (1.0, 2.3) | 1.9 (1.1, 3.4) | 0.000 |
WBC (× 109/L) | 10 (7.5, 13) | 9.3 (6.7, 12.7) | 0.105 |
NEUTP (%) | 73 (65, 82) | 79.3 (71, 84) | 0.000 |
RBC (× 1012/L) | 2.9 (2.3, 3.7) | 2.6 (2, 3.3) | 0.001 |
HGB (g/L) | 87 (67, 111) | 81 (60, 98) | 0.007 |
RDW (%) | 13.5 (12.6, 16.2) | 14.8 (13.6, 18.1) | 0.000 |
PLT (× 109/L) | 222 (160, 273) | 144 (100, 200) | 0.000 |
PDW (%) | 11.6 (10.1, 13.2) | 12 (10.4, 15) | 0.015 |
Alb (g/L) | 34 (29, 38) | 29 (24, 33) | 0.000 |
BUN (mmol/L) | 10.1 (6.3, 14.1) | 9.7 (5.2, 12.6) | 0.031 |
PT (sec) | 12 (11.5, 13.2) | 13.9 (12.2, 17) | 0.000 |
APTT (sec) | 23.5 (22, 25.8) | 26.3 (22.8, 29.5) | 0.000 |
TT (sec) | 18.5 (17.5, 19.4) | 19 (17.9, 20.4) | 0.000 |
FIB (g/L) | 2.04 (1.7, 2.57) | 1.79 (1.3, 2.6) | 0.000 |
D-DIMER (mg/L) | 0.39 (0.19, 1.12) | 0.98 (0.3, 3) | 0.000 |
AIMS65 score | 1 (0, 1) | 1 (0, 2) | 0.000 |